Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer

Summary

This phase II trial studies how well eribulin mesylate works in treating patients with previously treated breast cancer that has spread to other places in the body. Drugs used in chemotherapy, such as eribulin mesylate, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Timeline

Start

2014-01-08

Primary completion

2019-05-04

Completion

2019-05-04

Drugs

Indications